The DOI matches its Crossref record; the references it cites are not checked yet.
The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study
Abstract
Twenty eight patients treated with selective serotonin reuptake inhibitors /venlafaxine were randomized to a three-day (short) or 14-day (longer) anti—depressant taper and openly assessed after a five to seven day drug-free washout, and again after seven days treatment with a new anti—depressant of the treating clinician's choice. A 'discontinuation syndrome' ( ≥ 3 new symptoms on the Discontinuation Emergent Signs and Symptoms checklist) occurred in 46% of patients with a similar frequency in those with short (7/15) versus longer (6/13) taper. Patients initially on short half-life anti—depressants had significantly greater increases in discontinuation and depressive symptoms than those stopping fluoxetine. Four patients, all on paroxetine, developed emergent suicidal ideation after taper. These results support the importance of half-life in determining discontinuation symptoms and suggest that there is little advantage to a two-week taper over a three-day taper when switching antidepressants. Antidepressant discontinuation in depressed patients can be associated with worsening depression and increased suicidality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Randomised studies show that tapering for up to 14 days either demonstrated no 16 or minimal 31 improvement in withdrawal symptom severity over abrupt discontinuation 32 .”
From Tapering of SSRI treatment to mitigate withdrawal symptoms (2019) · cites this paper as [16]
In the citing paper
“Serious symptoms may also include suicidal ideation and behaviour (Bloch et al., 1995; Kostic et al., 2024; Tint et al., 2008).”
From Post-acute withdrawal syndrome (PAWS) after stopping antidepressants: a systematic review with meta-narrative synthesis (2025) · cites this paper as Tint et al., 2008
In the citing paper
“Randomised studies show that tapering for up to 14 days either demonstrated no 16 or minimal 31 improvement in withdrawal symptom severity over abrupt discontinuation 32 .”
From Tapering of SSRI treatment to mitigate withdrawal symptoms (2019) · cites this paper as [16]
In the citing paper
“Such disturbances appear to be quite common on patients' websites [30] but await adequate exploration in clinical studies.”
From Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review (2015) · cites this paper as [30]
In the citing paper
“Communication about discontinuation faces a challenge similar to that faced by research on discontinuation: it can be difficult to define and distinguish between withdrawal effects and psychiatric symptoms (11).”
From Discontinuing Psychiatric Medications: A Survey of Long-Term Users (2017) · cites this paper as [11]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
The citation lists are queued
They are fetched later and appear here then.
Cited by 13
Metadata
- Authors
- Tint, A., Haddad, P. M., & Anderson, I. M.
- Affiliations
- University of Manchester (GB)
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2008-05-30
- ISSN
- 0269-8811 (ISSN-L)
- OpenAlex
- W4241869764
- Semantic Scholar
- 4df471240306cc2e67060874986c11a6625bb1ed
- Cited by
- 13
- References
- 0
- Citations by year
- 2025: 1 · 2023: 1 · 2022: 2 · 2019: 1 · 2018: 1 · 2017: 1 · 2015: 1 · 2014: 1 · 2013: 1 · 2012: 1
- FWCI
- 0.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Psychopharmacology (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- antidepressant tapering, discontinuation symptoms, selective serotonin reuptake inhibitors, venlafaxine, fluoxetine, paroxetine, elimination half-life, antidepressant switching, suicidal ideation, depression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study. https://app.cochat.ai/papers/10.1177/0269881107087488
- The paper
- Tint, A., Haddad, P. M., & Anderson, I. M. (2008). The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study. Journal of Psychopharmacology. https://doi.org/10.1177/0269881107087488
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.